US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Mesalamine Delayed-Release Tablets

Reason Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing.

Teva Pharmaceuticals USA NDC 0591-2245-22 D-0069-2021
Class II · Moderate risk Terminated

Hydrocodone Bitartrate and Acetaminophen Tablets

Reason Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.

Ascent Pharmaceuticals, Inc. NDC 31722-943-01 D-0097-2021
Class II · Moderate risk Terminated

Union

Reason CGMP Deviations

H & H Remedies, LLC D-0071-2021
Class II · Moderate risk Terminated

Metformin HCL E/R 500 mg

Reason CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

Direct Rx NDC 72189-064-90 D-0058-2021
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended Release 750 mg

Reason CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

RemedyRepack Inc. NDC 70518-2480-00 D-0050-2021
Class II · Moderate risk Terminated

N-A-C

Reason Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.

Jarrow Formulas Inc D-0302-2021
Class II · Moderate risk Terminated

Salicylic Acid Shampoo 3%

Reason GMP Deviations

Milbar Laboratories, Inc. D-0096-2021
Class II · Moderate risk Terminated

DCL Alpha Beta Gel Toner

Reason GMP Deviations

Milbar Laboratories, Inc. D-0094-2021
Class II · Moderate risk Terminated

Willa Pore Perfector

Reason GMP Deviations

Milbar Laboratories, Inc. D-0093-2021
Class II · Moderate risk Terminated

Willa Clear Skin

Reason GMP Deviations

Milbar Laboratories, Inc. D-0092-2021
Class II · Moderate risk Terminated

DCL AHA Lightening Gel

Reason GMP Deviations

Milbar Laboratories, Inc. D-0085-2021